1. Evolution of tumour biology upon progression. Do we know our enemy?

   • Ana Lluch
   • Ana Bosch

   Editorial Pages: 399 - 400

2. Merkel cell carcinoma: What do we know about it and what should we do?

   • Isabel Prieto Muñoz
   • José Pardo Masferrer
   • Ana M. Pérez Casas

   Educational Series Pages: 401 - 412

3. Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles

   • Juan Bayo
   • Paula J. Fonseca
   • Agustí Barnadas

   Educational Series Pages: 413 - 422

4. Functions and workload of medical oncologists in Spain

   • Cristina Grávalos
   • Javier Salvador
   • Emilio Alba

   Special Article Pages: 423 - 429

5. Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study

   • Pedro Sánchez-Rovira
   • Antonio Antón
   • José Luis Palacios

   Research Articles Pages: 430 - 436

6. Clinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancer

   • Xiao-Dong Jiang
   • Peng Dai
   • Shi-Qiu Li

   Research Articles Pages: 437 - 443

7. Expanding Sca-1⁺ mammary stem cell in the presence of oestrogen and growth hormone

   • Xiaowei Dou
   • Bin Zhang
   • Robert Chunhua Zhao

   Research Articles Pages: 444 - 451

8. Biological markers of cisplatin resistance in advanced testicular germ cell tumours

   • Adelaida García-Velasco
   • Ignacio Durán
   • Luis Paz-Ares

   Research Articles Pages: 452 - 457

9. Trends in prostate cancer survival in Spain: results from population-based cancer registries

   • Rafael Marcos-Gragera
   • Diego Salmerón
   • María-Dolores Chirlaque

   Research Articles Pages: 458 - 464

10. Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

    • Xiao-Dong Jiang
    • Yun Qiao
    • Yue-Wei Fan

    Research Articles Pages: 465 - 470

11. Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience

    • Robert Díaz Beveridge
    • Jorge Aparicio
    • David Ramos

    Research Articles Pages: 471 - 480

12. Behaviour of breast cancer molecular subtypes through tumour progression

    • Carlos A. Castaneda
    • Eva Andrés
    • Eva Ciruelos

    Research Articles Pages: 481 - 485

13. Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy

    • Cesar Gómez-Raposo
    • Mónica Andreu
    • Enrique Casado

    Brief Research Articles Pages: 486 - 488